OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's Disease: Risk Factor Modification and Prevention
Suraj Rajan, Bonnie Kaas
Seminars in Neurology (2022) Vol. 42, Iss. 05, pp. 626-638
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 1

Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
Kenneth Marek, David Russell, Luis Concha‐Marambio, et al.
EBioMedicine (2025) Vol. 112, pp. 105567-105567
Open Access | Times Cited: 1

Trends in mortality and disparities in dilated cardiomyopathy across gender, race, and region in the United States (1999-2020)
T Ashraf, Omar Abunada, Aashish Kumar, et al.
Annals of Medicine and Surgery (2025) Vol. 87, Iss. 3, pp. 1589-1598
Open Access

Plasma Metabolites as Mediators Between Gut Microbiota and Parkinson’s Disease: Insights from Mendelian Randomization
Jianzhun Chen, Liuhui Zhu, Fang Wang, et al.
Molecular Neurobiology (2025)
Closed Access

Amantadine Reduces Adverse Cardiovascular Outcomes in Patients With Parkinsonism or Parkinson Disease: A Global Propensity Score Matched Analysis
Dan Draytsel, Anderson Anuforo, Subaina Khalid, et al.
Clinical Neuropharmacology (2025)
Closed Access

Synergistic Neuroprotective and Immunomodulatory Effects of Cocoa Seed Husk and Guarana Extract: A Nutraceutical Approach for Parkinson’s Disease Management
Vitória Farina Azzolin, Verônica Farina Azzolin, Euler Esteves Ribeiro, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 348-348
Open Access

GDF15 attenuates Parkinson's disease progression via suppressing the activation of cGAS-STING pathway
Jianli Wang, Ting Geng, Xiaomei Yao, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access

Neuroprotective Potentials of Berberine in Rotenone-Induced Parkinson’s Disease-like Motor Symptoms in Rats
Hsiang-Chien Tseng, Mao‐Hsien Wang, Chih-Hsiang Fang, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 596-596
Open Access | Times Cited: 3

Identification of necroptosis-related genes in Parkinson’s disease by integrated bioinformatics analysis and experimental validation
Lei Cheng, Zhong-Yan Zhou, Wenting Shi, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8

METTL14 Regulates the m6A Modification of TRAF6 to Suppress Mitochondrial Dysfunction and Ferroptosis in Dopaminergic Neurons via the cGAS-STING Pathway
Liang Shao, Fan Hu, Renxu Xu, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 12, pp. 1518-1528
Closed Access | Times Cited: 7

Association of urinary chlorpyrifos, paraquat, and cyproconazole levels with the severity of fatty liver based on MRI
Peiqi Ma, Hongliang Gao, Ning Shen, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Current insights and assumptions on α-synuclein in Lewy body disease
Rehana K. Leak, Rachel N. Clark, Muslim Abbas, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 2

The relationship between Parkinson’s disease and sexual hyperactivity secondary to drug treatment: A systematic review
Verónica Aparicio-López, María Rueda-Extremera, María Cantero-García
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 2

Neuroprotective Efficacy of a Nanomicellar Complex of Carnosine and Lipoic Acid in a Rat Model of Rotenone-Induced Parkinson’s Disease
О. И. Куликова, Dmitry Troshev, D. S. Berezhnoy, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1215-1215
Open Access | Times Cited: 5

Syagrus coronata fixed oil prevents rotenone-induced movement disorders and oxidative stress in Drosophila melanogaster
Ricardo Gomes dos Santos Nunes, Luciclaudio Cassimiro de Amorim, Iverson Conrado Bezerra, et al.
Journal of Toxicology and Environmental Health (2024) Vol. 87, Iss. 12, pp. 497-515
Closed Access | Times Cited: 1

Xanthine or hypoxanthine or both may play therapeutical effect in Parkinson's disease through the endocannabinoid system
Bowen Chang, Chaoshi Niu, Yuge Jiang
Medical Hypotheses (2023) Vol. 182, pp. 111231-111231
Closed Access | Times Cited: 4

General Overview of Toxicology
Tyler Collier Vandivort, Warren Casey, David L. Eaton
Elsevier eBooks (2024)
Closed Access | Times Cited: 1

The Evolving Landscape of Parkinson's Disease Research: Current Challenges and Future Outlook
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
(2024)
Open Access | Times Cited: 1

MECANISMOS MOLECULARES DA DEGENERAÇÃO NEURONAL NA DOENÇA DE PARKINSON: UMA REVISÃO BIBLIOGRÁFICA
Ana Maria Santos Cardoso, Renata Azevedo Dutra Queiroz, Luana Elisa Lugli, et al.
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2024) Vol. 5, Iss. 1, pp. e514810-e514810
Open Access

Evaluation of the Effect of Age-Related Macular Degeneration Type And Stage on the Risk of Parkinson’s Disease
Erdoğan Yaşar, Uğur Gürlevik, Mustafa Değer Bilgeç, et al.
OSMANGAZİ JOURNAL OF MEDICINE (2024) Vol. 46, Iss. 3, pp. 423-429
Open Access

Page 1 - Next Page

Scroll to top